Your browser doesn't support javascript.
loading
Acute tubulointerstitial nephritis associated with atezolizumab, an anti-programmed death-ligand 1 (pd-l1) antibody therapy.
Xipell, M; Victoria, I; Hoffmann, V; Villarreal, J; García-Herrera, A; Reig, O; Rodas, L; Blasco, M; Poch, E; Mellado, B; Quintana, L F.
Affiliation
  • Xipell M; Nephrology and Renal Transplantation Department, Hospital Clínic, IDIBAPS, Universitat de Barcelona, Barcelona, Spain.
  • Victoria I; Oncology Department, Hospital Clínic, IDIBAPS, Universitat de Barcelona, Barcelona, Spain.
  • Hoffmann V; Nephrology and Renal Transplantation Department, Hospital Clínic, IDIBAPS, Universitat de Barcelona, Barcelona, Spain.
  • Villarreal J; Nephrology and Renal Transplantation Department, Hospital Clínic, IDIBAPS, Universitat de Barcelona, Barcelona, Spain.
  • García-Herrera A; Pathology Department, Hospital Clínic, IDIBAPS, Universitat de Barcelona, Barcelona, Spain.
  • Reig O; Oncology Department, Hospital Clínic, IDIBAPS, Universitat de Barcelona, Barcelona, Spain.
  • Rodas L; Nephrology and Renal Transplantation Department, Hospital Clínic, IDIBAPS, Universitat de Barcelona, Barcelona, Spain.
  • Blasco M; Nephrology and Renal Transplantation Department, Hospital Clínic, IDIBAPS, Universitat de Barcelona, Barcelona, Spain.
  • Poch E; Nephrology and Renal Transplantation Department, Hospital Clínic, IDIBAPS, Universitat de Barcelona, Barcelona, Spain.
  • Mellado B; Oncology Department, Hospital Clínic, IDIBAPS, Universitat de Barcelona, Barcelona, Spain.
  • Quintana LF; Nephrology and Renal Transplantation Department, Hospital Clínic, IDIBAPS, Universitat de Barcelona, Barcelona, Spain.
Oncoimmunology ; 7(7): e1445952, 2018.
Article in En | MEDLINE | ID: mdl-29900063

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Risk_factors_studies Language: En Journal: Oncoimmunology Year: 2018 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Risk_factors_studies Language: En Journal: Oncoimmunology Year: 2018 Document type: Article